FAST Act Would Provide Patients with Accelerated Access to Innovative Therapies

Mar 6 2012
The FAST Act will modernize the Accelerated Approval pathway to expedite the development of modern, targeted, and personalized therapies for patients suffering from serious and life-threatening diseases, while preserving the Food and Drug Administration's (FDA) robust standards for safety and effectiveness. 

Biotech Leader Provides Testimony at Congressional Hearing on ‘Spurring Job Growth through Capital Formation While Protecting Investors’

Mar 6 2012
OncoMed Pharmaceuticals SVP/CFO provided testimony today on behalf of BIO at a Senate Committee on Banking, Housing, and Urban Affairs 

BIO Applauds Senator Stabenow’s Proposed Legislation Supporting Creation of a Biobased Economy

Mar 5 2012
New "Grow It Here, Make It Here" legislation introduced today by Sen. Debbie Stabenow (D-Mich.) would help bio-based manufacturers access vital capital, strengthen market opportunities for biobased products, and spur commercialization of agricultural and industrial biotech innovations.

BIO Announces Expansion of Alliance Development Activities

Mar 2 2012
The Biotechnology Industry Organization (BIO) announced today that it has integrated its alliance development activities into one department as a means of expanding engagement opportunities with external groups that share a commitment to unleashing biotechnology’s capability to benefit patients and consumers.

Global Leaders in Advanced Biofuels Industry Urge Congressional Leaders to Extend Critical Tax Provisions

Feb 29 2012
Member companies of three leading advanced and cellulosic biofuel trade organizations sent a letter to House and Senate leaders asking for extension of the Cellulosic Biofuels Production Tax Credit, which expires December 31, 2012.

Commercialization of Advanced Biofuels to be Key Theme at BIO World Congress on Industrial Biotechnology and Bioprocessing

Feb 29 2012
Continued commercialization of the industrial biotechnology sector can drive the creation of a biobased economy, which can strengthen the nation’s economic security and enhance energy security. 

BIO Applauds Strengthening of the USDA BioPreferred Program

Feb 21 2012
BIO welcomes a White House memo to federal agencies that expands and strengthen the USDA BioPreferred program.

BIO Applauds Sen. Stabenow’s Grow It Here, Make It Here Initiative

Feb 21 2012
BIO thanks Sen. Debbie Stabenow (D-Mich.) for announcing policy proposals in Detroit that will spur commercialization of new agricultural innovations, increase access to capital and create a new tax cut for biobased manufacturers.

BIO Asks EPA to Reject Retroactive Changes to Renewable Fuel Standard

Feb 17 2012
BIO submitted a letter to EPA asking that they reject a retroactive reduction of the 2011 Renewable Fuel Standard obligations, requested in January by petroleum refiners.

BIO Plenary Speakers for the 2012 World Congress on Industrial Biotechnology and Bioprocessing to Address Advanced Biofuels, Renewable Chemicals and Creation of a Biobased Economy

Feb 16 2012
Company executives, scientists and government officials will bring a global perspective as featured presenters at BIO’s 9th annual World Congress on Biotechnology and Bioprocessing.